CAH #1 - WASHINGTON
1. Target Overview & Investment Thesis
CAH #1 - WASHINGTON is a 25-bed rural/critical access in WASHINGTON, NC with $13.8M in net patient revenue and a -25.3% operating margin. The hospital serves a payer mix of 60.2% Medicare, 27.1% Medicaid, and 12.7% commercial.
Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -25.3% to -18.0% (+737bps).
| Net Revenue HCRIS | $13.8M |
| Current EBITDA COMPUTED | $-3.5M |
| Operating Margin COMPUTED | -25.3% |
| Occupancy HCRIS | 32.2% |
| Revenue / Bed COMPUTED | $553K |
| Net-to-Gross HCRIS | 52.6% |
| Distress Probability ML | 62.4% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -25.3% places it below the state median. Among 38 size-comparable peers (12-50 beds), the median margin is -3.3%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 38 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CAH #1 - WASHINGTON (Target) | NC | 25 | $13.8M | -25.3% |
| DAVIE MEDICAL CENTER | NC | 42 | $108.5M | 27.5% |
| NOVANT HEALTH MINT HILL MEDICA | NC | 36 | $107.8M | 9.7% |
| THE OUTER BANKS HOSPITAL | NC | 21 | $93.7M | 26.2% |
| MEDICAL PARK HOSPITAL | NC | 22 | $82.6M | 15.8% |
| GRANVILLE MEDICAL CENTER | NC | 42 | $81.5M | -5.4% |
| NORTH CAROLINA SPECIALTY HOSPI | NC | 18 | $71.6M | 11.7% |
| CAPE FEAR VALLEY HOKE HOSPITAL | NC | 41 | $71.5M | 19.3% |
| THE MCDOWELL HOSPITAL | NC | 30 | $65.7M | -6.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $290K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $276K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $274K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $168K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +7bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-3.5M |
| + RCM Uplift | +$1.0M |
| Pro Forma EBITDA | $-2.5M |
| Current Margin | -25.3% |
| Pro Forma Margin | -18.0% |
| WC Released (1x) | $530K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-5.4M | $-12.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-5.4M | $-16.0M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-4.9M | $-14.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-4.9M | $-17.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-5.9M | $-16.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-5.9M | $-19.8M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 60.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Medium | Elevated Medicaid exposure (27.1%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 32.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 62.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 38 hospitals with 12-50 beds
- Same-state prioritization (n=39)
- Comp margins: P25=-20.3% / P50=-3.3% / P75=5.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.